Skip to main content
Download PDF

Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007–2012

BMC Endocrine Disorders volume 21, Article number: 224 (2021) Cite this article

Abstract

Purpose

Many smaller studies have previously shown a significant association between thyroid autoantibody induced hypothyroidism and lower serum vitamin D levels. However, these finding have not been confirmed by large-scale studies. In this study, we evaluated the relationship between hypothyroidism and vitamin D levels using a large population-based data.

Methods

For this study, we used National Health and Nutrition Examination Survey (NHANES) during the years 2007–2012. We categorized participants into three clinically relevant categories based on vitamin D levels: optimal, intermediate and deficient. Participants were also split into hypothyroid and hyperthyroid. Weighted multivariable logistic regression analyses were used to calculate the odds of being hypothyroid based on vitamin D status.

Results

A total of 7943 participants were included in this study, of which 614 (7.7%) were having hypothyroidism. Nearly 25.6% of hypothyroid patients had vitamin D deficiency, compared to 20.6% among normal controls. Adjusted logistic regression analyses showed that the odds of developing hypothyroidism were significantly higher among patients with intermediate (adjusted odds ratio [aOR], 1.7, 95% CI: 1.5–1.8) and deficient levels of vitamin D (aOR, 1.6, 95% CI: 1.4–1.9).

Conclusion

Low vitamin D levels are associated with autoimmune hypothyroidism. Healthcare initiatives such as mass vitamin D deficiency screening among at-risk population could significantly decrease the risk for hypothyroidism in the long-term.

Peer Review reports

Introduction

Hypothyroidism is an endocrine disorder characterized by lower serum levels of thyroxin, resulting in clinical spectrum that varies from no signs and symptom to life threatening complications [1, 2]. The major circulating thyroid hormone consists of thyroxine (Total T4), triiodothyronine (Total T3) and their free forms, free T4 (fT4) and free T3 (fT3) [3]. Blood levels are tightly regulated by the hypothalamus-pituitary-thyroid axis through a negative feedback mechanism [4].. Classically, primary overt hypothyroid cases will have low serum levels of fT4 and reciprocally elevated thyroid stimulating hormone (TSH) [1, 5]. The disease spectrum also consists of an occult condition known as subclinical hypothyroidism which is characterized by normal total T4 levels but modestly elevated TSH [6]. As per National Health and Nutrition Examination Survey (NHANES III) of United Sates population (1988 to 1994) the overall prevalence of hypothyroidism is 4.6% of which 0.3% have overt and 4.3% have subclinical hypothyroidism [6]. Hypothyroidism due to iodine deficiency is highly prevalent in geographical regions where the soil is deficient in iodine, such as hilly and mountainous terrain, whereas in iodine sufficient areas autoimmune etiology (Hashimoto’s thyroiditis) predominates [7].

Vitamin D is a fat-soluble nutrient that is canonically converted in vivo to active hormone (calcitriol or 1,25-dihydroxycholecalciferol) following two hydroxylation steps, first in the liver (calcidiol or 25-hydroxy vitamin D), and second in the kidneys. Circulating vitamin D status is evaluated by quantitation of serum 25-hydroxy vitamin D. Vitamin D has two forms. Namely vitamin D2 and vitamin D3. Vitamin D2 is obtained from plant sterol ergosterol and vitamin D3 (cholecalciferol) is derived from cholesterol under the skin [8]. Vitamin D is essential for maintenance of healthy body systems including the immune system and has protective role in cancer prevention [9]. Vitamin D deficiency is prevalent in both developed and developing countries and is determined by low serum 25-hydroxy vitamin D (< 25 nmol/l) levels [10]. In the US, overall vitamin D deficiency prevalence rate was 41.6% and highest in blacks followed by Hispanics [11].

Hashimoto’s thyroiditis is characterized by hemopoietic lymphocytic infiltration and subsequent autoimmune mediated destruction of the thyroid follicles resulting in variable clinical presentations, ranging from euthyroid to subclinical to frank hypothyroid state with or without evident goiter [12]. Different clinicopathological types have been reported and is characterized by circulating antibodies against thyroid peroxidase (TPO) and thyroglobulin (Tg). TPO is primarily involved in the synthesis of thyroid hormone (T4 and T3) while Tg sequesters thyroid hormones within thyroid follicles [12, 13]. Epidemiologically, the incidence is more common in females than in males and lower among alcoholics and smokers [14]. Etiopathogenesis involves genetic predisposition and environmental factor that are newly associated with vitamin D and selenium deficiency. Vitamin D has immunoregulatory and anti-inflammatory functions such as regulating the activity of the adaptive immune system, especially the low dendritic cell differentiation, enhanced Th2 helper cells (shifting from Th1 to Th2 helper cells) maturation, and activation of T regulatory (Treg) cells [15]. Low vitamin D levels are significantly correlated with the development of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type 1 diabetes mellitus, multiple sclerosis, and autoimmune thyroid diseases [16]. A meta-analysis that looked for vitamin D levels in autoimmune thyroiditis showed that both Hashimoto thyroiditis and Grave’s disease were associated with lower vitamin D levels [17]. Conversely, some studies have shown that there was no significant association between vitamin D and auto immune thyroiditis [18]. In this study, we observed the relationship between vitamin D and hypothyroidism using a large nationally representative NHANES data.

Methods and materials

Study design

For this study, we used National Health and Nutrition Examination Survey (NHANES) during the years 2007–2012. The NHANES is a nationwide survey on the health and nutritional status of the US population and include all noninstitutionalized people and is conducted by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). NHANES uses complex, multistage cluster probability sampling design for conducting the survey and participants are randomly selected for the survey. Data for the survey are gathered by conducting interviews of the participants at their homes, and a selected number of these participants are invited for medical examinations and laboratory evaluations done at Mobile Examination Centers (MECs). Survey protocol for NHANES data collection is approved by the NCHS institutional review board.

Study population

For this study, we used data from participants ≥20 years of age. All NHANES participants who were ≥ 18 years of age had signed a written informed consent following an extensive and detailed description about the survey including the interview, medical examination and laboratory evaluation. Details of the of the methods and protocols for the questionnaires, laboratory, and examination can be found elsewhere [19].

Vitamin D status

For this study, we categorized participants into three clinically relevant categories based on the serum 25(OH) D levels following the Endocrinology Society Clinical Practice Guidelines [20]. The three categories are optimal (≥30 ng/mL), intermediate (20 to < 30 ng/mL) and deficient (< 20 ng/mL) vitamin D levels.

Hypothyroidism

We used the laboratory reference range of thyroid stimulating hormone (TSH), 0.34–5.60 mIU/L, from manufacturer’s studies, for diagnosing hypothyroidism [21]. Participants were defined as hypothyroid if their TSH was more than 5.60 mIU/L or were on levothyroxine. Participants were categorized as normal controls if their TSH was between 0.34–5.60 mIU/L and they were not taking any thyroid medication.

The study was reviewed by the Miami Cancer Institute’s Institutional Review Board, which exempted the study from institutional review board approval and waived the requirement for informed consent because it uses previously collected deidentified data stored in NHANES.

Statistical analysis

Statistical analysis was performed using SAS (version 9.4, SAS Institute, Cary, North Carolina), which accounted for the complex survey design and clustering. Demographic and socioeconomic measures were compared between hypothyroid patients and normal controls using independent samples t test for continuous variables and Chi-square test for categorical variables. Similarly, clinical characteristics of hypothyroid patients and normal controls were compared. Weighted multivariable logistic regression analyses were used to calculate the odds of being hypothyroid based on vitamin D status, after adjusting for covariates such as age, education, income, smoking, alcohol consumption, body mass index (BMI), physical activity, hypertension, diabetes, dyslipidemia, blood urea nitrogen, creatinine and magnesium levels. The NHANES measures physical activity using the physical activity questionnaire. Whether the recommended level of physical activity was met (yes or no) was ascertained through this questionnaire, which included the duration of moderate to vigorous intensity leisure-time physical activities performed for a minimum of 10 min at a time in the previous month. Age, race, education, income, smoking, alcohol consumption, and physical activity were self-reported by participants during house visits for surveys. Height and weight for BMI, systolic and diastolic blood pressures, fasting blood glucose, glycated haemoglobin, serum lipid profile, blood urea nitrogen, creatinine and magnesium levels were measured by trained healthcare professionals during Medical Examination Center visits. Since the proportion of missing data was small and not missing completely on random, NOMCAR option was used during the regression analysis. Statistical significance was set at P < 0.05.

Results

A total of 7943 participants were included in this study, of which 614 (7.7%) were having hypothyroidism. The man age of this cohort was 47.0 (SE = 0.3) years and 51.5% were females. Majority of the participants were white (69.7%), followed by blacks (10.2%) and Mexican Americans (8.1%). About 57.5% of the participants had more than 12 years of formal education. About 37.4% of participants were in the highest income group and 14.3% were in the lowest income group. Majority of the participants (80.8%) reported that they had health insurance. More than half of the participants (58.1%) reported that they had engaged in some form of physical activity and 75.8% never smoked and 78.1% currently consumed alcohol. Significant differences were observed in all demographics and socioeconomic factors between hypothyroid patients and normal control (Table 1).

Table 1 Demographic and socioeconomic characteristics of the participants, NHANES 2007–2012 (n = 7943)
Full size table

Comparison of clinical characteristics between hypothyroid patients and normal controls also showed significant difference in majority of the factors. There was a significant association (P < 0.001) between vitamin D categories and hypothyroid state (Fig. 1). Nearly 25.6% of hypothyroid patients had vitamin D deficiency, compared to 20.6% in normal controls. Majority of participants in the hypothyroid group were obese (40.5%), while 33.4% were obese in the normal controls. Significantly higher proportion of participants in the hypothyroid group were hypertensive (47.1% versus 29.5%, P < 0.001), diabetic (19.7% versus 10.7%, P < 0.001), and dyslipidemic (54.9% versus 44.7%, P < 0.001). Similarly, there were significant mean differences in majority of biochemical variables between hypothyroid patients and normal controls. Details are shown in Table 2.

Fig. 1
figure 1

Comparison of vitamin D categories by hypothyroidism and normal control

Full size image
Table 2 Clinical characteristics of the participants, NHANES 2007–2012 (N = 7943)
Full size table

Unadjusted logistic regression analyses or those adjusted for selected covariates (age, sex, race, smoking, alcohol consumption, BMI and physical activity) did not show any association between vitamin D deficiency and hypothyroidism. However, logistic regression analyses adjusted for age, race, education, income, smoking, alcohol consumption, BMI, physical activity, hypertension, diabetes, dyslipidemia, blood urea nitrogen, creatinine and magnesium showed that the odds of developing hypothyroidism were significantly higher among patients with intermediate (adjusted odds ratio [aOR], 1.7, 95% CI: 1.5–1.8) and deficient levels of vitamin D (aOR, 1.6, 95% CI: 1.4–1.9). All regression models are shown in Table 3. Table 4 shows correlation between variables included in the regression models.

Table 3 Multivariable logistic regression results showing association between vitamin D and hypothyroidism (N = 7943)
Full size table
Table 4 Correlation between variables included in the regression models
Full size table

Discussion

This study evaluated the association between vitamin D levels and hypothyroidism using a large nationally representative database. Earlier studies on smaller populations have shown an inverse relationship between vitamin D levels and the occurrence of hypothyroidism [22,23,24,25]. We have studied the association in 7943 participants who enrolled in the NHANES during the period 2007–2012 and included 614 hypothyroid participants.

In our study, hypothyroid group had a mean age significantly higher than the control participants and majority of participant cases were females. Similar findings were found in a study by Mackawy et al. which had greater number of female subjects with hypothyroidism [25]. Other studies done in middle income countries such as India as reported by Velayutham et al. and Unnikrishnan et al. also had greater number of female patients with hypothyroidism [26, 27]. This shows that regular thyroid evaluation of females early in the middle ages is necessary to diagnose and initiate treatment in the early course of the illness. Kim et al. observed that premenopausal females are at a higher risk of developing autoimmune hypothyroidism compared to men and even postmenopausal females [28].

Majority of the hypothyroid subjects in our study were non-Hispanic whites. Schectman et al. studied 809 age and sex matched suspected cases of hypothyroidism and observed that mean TSH in blacks were significantly lower compared to whites [29]. This study inferred that racial parameter contributed to 6.5% variation in TSH levels. Olmos et al. in the ELSA-Brazil (Brazilian longitudinal study on adult health) study observed higher prevalence of overt hypothyroidism in whites, compared to brown and black population [30]. It signifies that brown and black ethnicity may have a protective effect from developing overt hypothyroidism. We also observed that a significant number of participants belonged to the highest income strata and majority had good education. This suggests that hypothyroid participants have the potential to comprehend the impact of the illness and take the necessary steps for effective treatment of the ailment. Similar findings were observed by Olmos et al. in their Brazilian population, where most of the hypothyroid subjects taking levothyroxine belonged to the high socioeconomic strata [30]. About 92% of hypothyroid participants in our study had health insurance coverages which could cover the medication cost.

In our study, lifestyle characteristics of participants showed that they had lower levels of physical activity and consumed alcohol, though majority of them never smoked. Ciloglu et al. reported that increased physical activity at the anaerobic threshold steadily increased the production of TSH, fT4, and T4 but produced a fall in total T3 and fT3 [31]. Thus, regular aerobic exercises may be beneficial in normal subjects to boost endogenous thyroid hormone synthesis. Bansal et al. reported that regular exercise could have a beneficial effect on the thyroid hormone status of hypothyroid subjects on treatment [32]. In our study, a significant majority of hypothyroid participants consumed alcohol. It is essential to note that alcohol has a negative effect over the thyroid function. Alcohol reduces the levels of peripheral thyroid hormones especially during late alcohol withdrawal and can aggravate hypothyroidism [33, 34]. Thus, abstinence from alcohol should be advised for patients diagnosed with hypothyroidism and who are on thyroid medications.

Vitamin D levels could be influenced by whether the physical activity is performed indoors or outdoors. Similarly, it could also be influenced by alcohol consumptions, which significantly increases vitamin D levels. Although, participants in our study reported lower levels of physical activity and alcohol consumption, there were no interaction of these variables with the relationship between vitamin D status and hypothyroidism.

Vitamin D deficiency is being recognized as a global pandemic most presumably due to heliophobia of the general population, especially among those residing in southeast Asia [35]. Thus, endocrinologist in such countries have recommended to increase the recommended daily allowance (RDA) for vitamin D to prevent deficiency states. Huotari and Herzig in their literature review on vitamin D status in populations living in higher latitudes recommended that vitamin D deficiency was highly predominant in the winter season and consumption of vitamin D fortified foods and supplements would be necessary to prevent deficiency states in these seasons [36]. Parva et al. using NHANES found that the prevalence of vitamin D deficiency was as high as 39% in the US population [37]. They also found out that the odds of having vitamin D deficiency were higher among black race and individuals with poor health and obesity. One of the key clinical condition observed in vitamin D deficiency was the increased incidence of autoimmune diseases [16]. Hypothyroidism is commonly a disease resulting from similar autoimmune insults as indicated by higher anti-peroxidase and anti-thyroglobulin antibodies [12, 13].

We found that participants having deficient vitamin D levels were significantly higher among hypothyroid participants, compared to normal controls. Conversely, participants with optimal vitamin D levels were significantly higher in control group, compared to hypothyroid participants. In a nutshell, 63.7% of the hypothyroid participants has sub-optimal levels of vitamin D as compared to controls (53.3%). This shows that prevalence of low vitamin D levels could be associated with increased risk of developing hypothyroidism, though we could not establish a causal relationship. Mackawy et al. in a small sample size of 30 subjects observed that vitamin D deficiency is associated with lower thyroid levels [25].

In our study, we found that the odds of developing hypothyroidism were significantly higher among patients with intermediate and deficient levels of vitamin D. Kim38 reported in Korean population that vitamin D deficiency is highly prevalent in autoimmune Hashimoto’s thyroiditis presenting with overt hypothyroidism than subclinical hypothyroid variants [38]. Studies have shown that a reciprocal relationship exists between serum TSH and vitamin D levels in hypothyroid subjects [38, 39]. ElRawi et al. reported vitamin D deficient hypothyroid subjects have higher insulin resistance which significantly correlated with higher anti-thyroid antibodies, anti-TPO and anti-Tg [39]. However, they did not observe any significant vitamin D receptor polymorphism in subject vs control suggesting that correction with vitamin D supplements may possibly have a therapeutic benefit in correcting thyroid status. Talaei et al. found that supplementation of 50,000 IU vitamin D to hypothyroid subject lowered TSH and parathormone levels without any significant effect over serum thyroxine (T3 and T4) levels [40]. In another scenario, Ucan et al. observed that a similar vitamin D oral supplementation to autoimmune Hashimoto’s thyroiditis subjects significantly improved thyroid status concurrent with a decrease in autoimmune antibodies and an increase in free T4 (fT4) levels [41]. Mirhosseini et al. in a large cohort found that a significant fraction of subjects had an improvement in their thyroid status following vitamin D supplementation [42]. A randomized control trial by Chahardoli et al. found that vitamin D supplementation significantly reduced the levels of tropic hormone TSH and anti-Tg antibodies [43]. However, this study did not find any significant differences with respect to anti-TPO levels and thyroxine levels between the groups. These finding suggest that vitamin D has a key role in regulating both the thyroid destroying autoimmune antibodies as well as the pituitary trophic hormone TSH. In another study, thyroidectomy in the past as well as subjects receiving thyroid supplementation therapy had higher vitamin D levels, compared to undertreated patients [44]. This suggest that undertreated hypothyroidism and progressive autoimmune inflammation mediated destruction of thyroid could have detrimental effect over vitamin D metabolism and could potentiate the systemic ill-health effects associated with thyroid dysfunction. Meta-analysis and case control study-based observations show that individuals with low vitamin D levels also have an increased risk of developing thyroid cancer [45].

In our study, we found a significant association between body mass index and hypothyroid state. Obesity or increased fat deposition is another risk factor for low vitamin D levels. Steroid derived hormones like vitamin D tend to get redistributed in the adipose tissue which function as a huge reservoir [46]. This results in a lower plasma level of circulating pre-vitamin D resulting in vitamin D deficiencies. Liel et al. reported low levels of circulating vitamin D in obese subjects compared to non-obese [47]. Vitamin D deficient hypothyroid patients also show an increased likelihood for developing diabetes mellitus, hypertension and anemia [48]. McGill et al. reported that vitamin D levels fall by 0.29 nmol/L for every centimeter increase in waist circumference due to abdominal obesity [49]. Hypothyroidism due to autoimmune destruction is highly associated with centripetal obesity with metabolic derangements where both anti-TPO and anti-Tg positively correlate with serum triglyceride levels and waist circumference [50]. Our study also show that hypothyroid subjects had significantly increased prevalence of diabetes mellitus, hypertension and dyslipidemia thus qualifying for metabolic syndrome. This suggest that metabolic alterations associated with hypothyroidism could be plausibly aggravated by vitamin D deficiency.

We used NHANES, which is a nationally representative data set. Because of the large sample size, we could make better estimates of the relationship between vitamin D and hypothyroidism. Therefore, our results would be generalizable to the entire U.S. population thereby assuring high levels of external validity. Most of the variables in our study are based on laboratory results. Hence, we could assure greater levels of internal validity of our results. Our study has some limitations. Since this study is cross-sectional, we could not infer causality in the association between vitamin D and hypothyroidism. In addition, we also excluded missing data which could have led to some confounding in the results. Due to the limitations NHANES data certain important variables related to vitamin D such as indoor versus outdoor physical activity, seasonal changes, and geographical coordinates could not be ascertained and could have led to some biases. Pathological conditions such as non-alcoholic fatty liver disease which could affect vitamin D also could not be determined. Some of the variables collected in the study such as smoking status, alcohol consumption, and physical activity, were self-reported and therefore susceptible to social desirability bias. Though we tried our best to account for potential confounders and covariates some residual confounders could still affect the findings in our study.

Conclusion

Our study highlights the association between vitamin D deficiency and hypothyroidism using a large nationally representative data. Future largescale experimental studies are needed to confirm the findings in our study. Based on the findings of our study, healthcare initiatives such as mass vitamin D deficiency screening among at-risk population such as elderly, obese, indoor and sedentary individuals and prompt treatment with dietary supplementations could significantly decrease the risk for hypothyroidism in the long-term.

Availability of data and materials

The dataset used in this study is publicly available from https://www.cdc.gov/nchs/nhanes/index.htm

References

  1. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550–62. https://doi.org/10.1016/S0140-6736(17)30703-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–34. https://doi.org/10.1001/archinte.160.4.526.

    Article  CAS  PubMed  Google Scholar 

  3. Kelly GS. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev. 2000;5(4):306–33.

    CAS  PubMed  Google Scholar 

  4. Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035–43. https://doi.org/10.1172/JCI60047.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Koulouri O, Gurnell M. How to interpret thyroid function tests. Clin Med (Lond). 2013;13(3):282–6.

    Google Scholar 

  6. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99. https://doi.org/10.1210/jcem.87.2.8182.

    Article  CAS  PubMed  Google Scholar 

  7. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39–51. https://doi.org/10.1093/bmb/ldr030.

    Article  PubMed  Google Scholar 

  8. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):752–7. https://doi.org/10.4065/mcp.2010.0138.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010;9(1):65–77. https://doi.org/10.1186/1475-2891-9-65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol. 2007;103(3–5):620–5. https://doi.org/10.1016/j.jsbmb.2006.12.076.

    Article  CAS  PubMed  Google Scholar 

  11. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54. https://doi.org/10.1016/j.nutres.2010.12.001.

    Article  CAS  PubMed  Google Scholar 

  12. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4–5):391–7. https://doi.org/10.1016/j.autrev.2014.01.007.

    Article  CAS  PubMed  Google Scholar 

  13. Fröhlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521–36. https://doi.org/10.3389/fimmu.2017.00521.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang Y, Cai L, Zheng Y, Pan J, Li L, Zong L, et al. Association between lifestyle and thyroid dysfunction: a cross-sectional epidemiologic study in the she ethnic minority group of Fujian Province in China. BMC Endocr Disord. 2019;19(1):83–91. https://doi.org/10.1186/s12902-019-0414-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–6. https://doi.org/10.2310/JIM.0b013e31821b8755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. D'Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev. 2015;14(5):363–9. https://doi.org/10.1016/j.autrev.2014.10.008.

    Article  CAS  PubMed  Google Scholar 

  17. Wang J, Lv S, Chen G, Gao C, He J, Zhong H, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015;7(4):2485–98. https://doi.org/10.3390/nu7042485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Musa IR, Gasim GI, Khan S, Ibrahim IA, Abo-Alazm H, Adam I. No association between 25 (OH) vitamin D level and hypothyroidism among females. Open Access Maced J Med Sci. 2017;5(2):126–30. https://doi.org/10.3889/oamjms.2017.029.

    Article  PubMed  PubMed Central  Google Scholar 

  19. National Health and Nutrition Examination Survey. https://www.cdc.gov/nchs/nhanes/index.htm. Accessed December 17, 2020.

  20. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. https://doi.org/10.1210/jc.2011-0385.

    Article  CAS  Google Scholar 

  21. Laboratory Procedure Manual. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/THYROD_e_met_Thyroid_Stimulating_Hormone.pdf. Accessed on March 08, 2021.

  22. Ke W, Sun T, Zhang Y, He L, Wu Q, Liu J, et al. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient. Endocr J. 2017;64(6):581–7. https://doi.org/10.1507/endocrj.EJ16-0547.

    Article  CAS  PubMed  Google Scholar 

  23. Metwalley KA, Farghaly HS, Sherief T, Hussein A. Vitamin D status in children and adolescents with autoimmune thyroiditis. J Endocrinol Investig. 2016;39(7):793–7. https://doi.org/10.1007/s40618-016-0432-x.

    Article  CAS  Google Scholar 

  24. Ahi S, Dehdar MR, Hatami N. Vitamin D deficiency in non-autoimmune hypothyroidism: a case-control study. BMC Endocr Disord. 2020;20(1):41–6.

    Article  CAS  Google Scholar 

  25. Mackawy AM, Al-Ayed BM, Al-Rashidi BM. Vitamin d deficiency and its association with thyroid disease. Int J Health Sci (Qassim). 2013;7(3):267–75. https://doi.org/10.12816/0006054.

    Article  Google Scholar 

  26. Velayutham K, Selvan SS, Unnikrishnan AG. Prevalence of thyroid dysfunction among young females in a south Indian population. Indian J Endocrinol Metab. 2015;19(6):781–4. https://doi.org/10.4103/2230-8210.167546.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Unnikrishnan AG, Kalra S, Sahay RK, Bantwal G, John M, Tewari N. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647–52. https://doi.org/10.4103/2230-8210.113755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kim CY, Lee YJ, Choi JH, Lee SY, Lee HY, Jeong DH, et al. The association between low vitamin D status and autoimmune thyroid disease in Korean premenopausal women: the 6th Korea National Health and nutrition examination survey, 2013-2014. Korean J Fam Med. 2019;40(5):323–8. https://doi.org/10.4082/kjfm.18.0075.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Schectman JM, Kallenberg GA, Hirsch RP, Shumacher RJ. Report of an association between race and thyroid stimulating hormone level. Am J Public Health. 1991;81(4):505–6. https://doi.org/10.2105/AJPH.81.4.505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Olmos RD, Figueiredo RC, Aquino EM, Lotufo PA, Bensenor IM. Gender, race and socioeconomic influence on diagnosis and treatment of thyroid disorders in the Brazilian longitudinal study of adult health (ELSA-Brasil). Braz J Med Biol Res. 2015;48(8):751–8. https://doi.org/10.1590/1414-431x20154445.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ciloglu F, Peker I, Pehlivan A, Karacabey K, Ilhan N, Saygin O, et al. Exercise intensity and its effects on thyroid hormones. Neuro Endocrinol Lett. 2005;26(6):830–4.

    CAS  PubMed  Google Scholar 

  32. Bansal A, Kaushik A, Singh CM, Sharma V, Singh H. The effect of regular physical exercise on the thyroid function of treated hypothyroid patients: an interventional study at a tertiary care center in Bastar region of India. Arch Med Health Sci. 2015;3(2):244–6. https://doi.org/10.4103/2321-4848.171913.

    Article  Google Scholar 

  33. Balhara YP, Deb KS. Impact of alcohol use on thyroid function. Indian J Endocrinol Metab. 2013;17(4):580–7. https://doi.org/10.4103/2230-8210.113724.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Ozsoy S, Esel E, Izgi HB, Sofuoglu S. Thyroid function in early and late alcohol withdrawal: relationship with aggression, family history, and onset age of alcoholism. Alcohol Alcohol. 2006;41(5):515–21. https://doi.org/10.1093/alcalc/agl056.

    Article  PubMed  Google Scholar 

  35. Mudur G. Indian endocrinologists set guidance to combat vitamin D deficiency. BMJ. 2015;351(nov09 4):h5997. https://doi.org/10.1136/bmj.h5997.

    Article  CAS  PubMed  Google Scholar 

  36. Huotari A, Herzig KH. Vitamin D and living in northern latitudes--an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008;67(2–3):164–78. https://doi.org/10.3402/ijch.v67i2-3.18258.

    Article  PubMed  Google Scholar 

  37. Parva NR, Tadepalli S, Singh P, Qian A, Joshi R, Kandala H, et al. Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012). Cureus. 2018;10(6):e2741. https://doi.org/10.7759/cureus.2741.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kim D. Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis. Hormones (Athens). 2016;15(3):385–93. https://doi.org/10.14310/horm.2002.1681.

    Article  Google Scholar 

  39. ElRawi HA, Ghanem NS, ElSayed NM, Ali HM, Rashed LA, Mansour MM. Study of vitamin D level and vitamin D receptor polymorphism in hypothyroid Egyptian patients. J Thyroid Res. 2019;2019:3583250–10. https://doi.org/10.1155/2019/3583250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Talaei A, Ghorbani F, Asemi Z. The effects of vitamin D supplementation on thyroid function in hypothyroid patients: a randomized, double-blind, placebo-controlled trial. Indian J Endocrinol Metab. 2018;22(5):584–8. https://doi.org/10.4103/ijem.IJEM_603_17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Ucan B, Sahin M, Sayki Arslan M, Colak Bozkurt N, Kizilgul M, Güngünes A, et al. Vitamin D treatment in patients with Hashimoto's thyroiditis may decrease the development of hypothyroidism. Int J Vitam Nutr Res. 2016;86(1):9–17. https://doi.org/10.1024/0300-9831/a000269.

    Article  CAS  PubMed  Google Scholar 

  42. Mirhosseini N, Brunel L, Muscogiuri G, Kimball S. Physiological serum 25-hydroxyvitamin D concentrations are associated with improved thyroid function-observations from a community-based program. Endocrine. 2017;58(3):563–73. https://doi.org/10.1007/s12020-017-1450-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Can supplementation with vitamin D modify thyroid autoantibodies (anti-tpo ab, anti-tg ab) and thyroid profile (t3, t4, tsh) in Hashimoto's thyroiditis? A double blind, randomized clinical trial. Horm Metab Res. 2019;51(5):296–301. https://doi.org/10.1055/a-0856-1044.

    Article  CAS  PubMed  Google Scholar 

  44. Lawnicka H, Galant-Gdula A, Motylewska E, Komorowski J, Swietoslawski J, Stepien H. Estimation of vitamin D status in patients with secondary and primary hypothyroidism of different etiology. Neuro Endocrinol Lett. 2018;38(8):565–4.

    PubMed  Google Scholar 

  45. Hu MJ, Zhang Q, Liang L, Wang SY, Zheng XC, Zhou MM, et al. Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis. J Endocrinol Investig. 2018;41(10):1199–210. https://doi.org/10.1007/s40618-018-0853-9.

    Article  CAS  Google Scholar 

  46. Carrelli A, Bucovsky M, Horst R, Cremers S, Zhang C, Bessler M, et al. Vitamin D storage in adipose tissue of obese and normal weight women. J Bone Miner Res. 2017;32(2):237–42. https://doi.org/10.1002/jbmr.2979.

    Article  CAS  PubMed  Google Scholar 

  47. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43(4):199–201. https://doi.org/10.1007/BF02555135.

    Article  CAS  PubMed  Google Scholar 

  48. Aldossari K, Al-Ghamdi S, Al-Zahrani J, Al Jammah A, Alanazi B, Al-Briek A, et al. Association between subclinical hypothyroidism and metabolic disorders: a retrospective chart review study in an emerging university hospital. J Clin Lab Anal. 2019;33(9):e22983. https://doi.org/10.1002/jcla.22983.

    Article  PubMed  PubMed Central  Google Scholar 

  49. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008;7(1):4–8. https://doi.org/10.1186/1475-2891-7-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Tamer G, Mert M, Tamer I, Mesci B, Kilic D, Arik S. Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol. 2011;62(5):421–8.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the millions of patients who contributed to the NHANES database and the numerous professionals who created the database.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Open Access funding enabled and organized by Projekt DEAL.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Government Medical College, Kozhikode, Kerala, India

    Sandeep Appunni

  2. Miami Cancer Institute, Miami, Florida, USA

    Muni Rubens, Raees Tonse & Peter McGranaghan

  3. Baptist Health South Florida, Miami, Florida, USA

    Venkataraghavan Ramamoorthy, Anshul Saxena, Emir Veledar & Peter McGranaghan

  4. Department of Biostatistics, Florida International University, Miami, FL, USA

    Emir Veledar

  5. Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA

    Emir Veledar

  6. Department of Internal Medicine and Cardiology, Charité - Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany

    Peter McGranaghan

Authors
  1. Sandeep Appunni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Muni Rubens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Venkataraghavan Ramamoorthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anshul Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raees Tonse
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emir Veledar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peter McGranaghan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Concept, design and acquisition of data: SA, MR, VR, and AS. Analysis and interpretation of data: VR, PM, MR, and AS. Drafting of article: SA, PM, RT, and MR. Critical revision: MR, AS, and VR. The author(s) read and approved the final manuscript.

Authors’ information

1Department of Biochemistry, Government Medical College, Kozhikode, Kerala, India, 2Miami Cancer Institute, Miami, Florida, USA, 3University of Central Florida, Warrensburg, Missouri, USA, 4Baptist Health South Florida, Miami, Florida, USA.

Corresponding author

Correspondence to Peter McGranaghan.

Ethics declarations

Ethics approval and consent to participate

The study was reviewed by the Miami Cancer Institute’s Institutional Review Board, which exempted the study from institutional review board approval and waived the requirement for informed consent because it uses previously collected deidentified data stored in NHANES.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Appunni, S., Rubens, M., Ramamoorthy, V. et al. Association between vitamin D deficiency and hypothyroidism: results from the National Health and Nutrition Examination Survey (NHANES) 2007–2012. BMC Endocr Disord 21, 224 (2021). https://doi.org/10.1186/s12902-021-00897-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12902-021-00897-1

Keywords

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us